Jpmorgan Chase & CO Trans Medics Group, Inc. Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 214,793 shares of TMDX stock, worth $18.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

214,793

Previous 109,741 95.73%

Holding current value

$18.3 Million

Previous $8.11 Million 298.72%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$72.62 - $150.62 $7.63 Million - $15.8 Million	105,052 Added 95.73%	214,793 $32.4 Million
Q1 2024 May 10, 2024	SELL	$70.86 - $89.93 $469,376 - $595,696	-6,624 Reduced 5.69%	109,741 $8.11 Million
Q4 2023 Feb 12, 2024	SELL	$36.74 - $81.08 $929,779 - $2.05 Million	-25,307 Reduced 17.86%	116,365 $9.18 Million
Q3 2023 Nov 14, 2023	BUY	$53.47 - $96.07 $1.63 Million - $2.93 Million	30,486 Added 27.42%	141,672 $7.76 Million
Q2 2023 Aug 11, 2023	BUY	$66.23 - $88.73 $762,373 - $1.02 Million	11,511 Added 11.55%	111,186 $9.34 Million
Q1 2023 May 18, 2023	BUY	$53.63 - $82.33 $2.09 Million - $3.21 Million	39,008 Added 64.3%	99,675 $7.55 Million
Q1 2023 May 11, 2023	BUY	$53.63 - $82.33 $1.54 Million - $2.37 Million	28,745 Added 90.05%	60,667 $4.59 Million
Q4 2022 Feb 13, 2023	BUY	$39.08 - $64.29 $144,908 - $238,387	3,708 Added 13.14%	31,922 $1.97 Million
Q3 2022 Nov 14, 2022	SELL	$31.56 - $55.75 $1.22 Million - $2.15 Million	-38,513 Reduced 57.72%	28,214 $1.18 Million
Q2 2022 Aug 11, 2022	BUY	$20.56 - $32.15 $1.11 Million - $1.73 Million	53,960 Added 422.65%	66,727 $2.1 Million
Q1 2022 May 11, 2022	BUY	$12.58 - $26.94 $32,594 - $69,801	2,591 Added 25.46%	12,767 $343,000
Q4 2021 Feb 10, 2022	BUY	$19.16 - $32.68 $8,986 - $15,326	469 Added 4.83%	10,176 $194,000
Q3 2021 Nov 12, 2021	BUY	$25.92 - $34.51 $251,605 - $334,988	9,707 New	9,707 $322,000

Others Institutions Holding TMDX

# of Institutions

363

Shares Held

29.6M

Call Options Held

395K

Put Options Held

152K

View Full List

About TransMedics Group, Inc.

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.7B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

More about TMDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Trans Medics Group, Inc. Transaction History